TNG908 (Ralometostat) Mechanism of Action: PRMT5 Inhibition in MTAP-Deleted Glioblastoma Cell Research

TNG908 (Ralometostat) MOA：Targeting PRMT5/Methionine Salvage Pathway for Glioblastoma and Brain Oncology

🎯 check TNG908 (Ralometostat) product page

TNG908 is a selective PRMT5 inhibitor. It affects SDMA signaling by MTA-cooperative inhibition, promoting MTAP-null cell death.

Primary Applications and Mechanism of Action

Jump to: